Benchmark Initiates Buy Rating on Palo Alto Networks with $200 Target
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 3 hours ago
0mins
Should l Buy PANW?
Source: seekingalpha
- Rating Upgrade: Benchmark has initiated coverage on Palo Alto Networks (PANW) with a Buy rating and a price target of $200, reflecting strong confidence in its future growth, projecting Next Gen Security ARR to more than double from $8.57 billion in FY26 to $20 billion by FY2030.
- Growth Potential: Analyst Yi Fu Lee highlighted that Palo Alto's Next Gen Security ARR grew by 32.4% year-over-year to $6.33 billion, indicating robust performance in the cybersecurity sector, especially when benchmarked against modern high-growth peers.
- Market Resilience: Benchmark asserts that while AI and Quantum Security have yet to be factored into projections, Palo Alto's business model and growth potential provide investors with an additional margin of safety, showcasing its competitive edge in the cybersecurity landscape.
- Industry Stability: Analysts noted that large language model providers like Anthropic and OpenAI are unlikely to disrupt cybersecurity and critical infrastructure software, reinforcing Palo Alto's solid position against AI threats and enhancing its appeal as a core holding.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PANW?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PANW
Wall Street analysts forecast PANW stock price to rise
34 Analyst Rating
28 Buy
5 Hold
1 Sell
Strong Buy
Current: 160.320
Low
157.00
Averages
232.49
High
265.00
Current: 160.320
Low
157.00
Averages
232.49
High
265.00
About PANW
Palo Alto Networks, Inc. is a global artificial intelligence (AI) cybersecurity company, with a comprehensive portfolio of cybersecurity solutions and platforms across network, cloud, security operations, AI and Identity. Its network security platform includes Secure Access Service Edge (SASE), Next-Generation Firewalls, Cloud Delivered Security Services (CDSS), Prisma AIRS, and Strata Cloud Manager (SCM). It delivers security operations capabilities that unifies standalone Security Information and Event Management (SIEM) tools, endpoint security, security automation, cloud detection and response (CDR), as well as attack surface management (ASM) capabilities on its Cortex platform. It delivers comprehensive security across the cloud application development lifecycle through Cortex Cloud. Its Unit 42 brings together expertise across threat research, incident response, and security consulting to deliver intelligence-driven, response-ready outcomes that help customers reduce cyber risk.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Eli Lilly Receives FDA Approval for New Drug Foundayo
- New Drug Approval: Eli Lilly announced that its once-daily GLP-1 drug Foundayo has received FDA approval and is set to launch on April 6 via the LillyDirect online platform, addressing strong market demand for weight loss medications and further solidifying its position in the obesity treatment market.
- Positive Market Outlook: Analysts forecast Foundayo to generate approximately $1.55 billion in sales this year, with projections growing to about $14.8 billion by 2030, indicating the drug's significant potential in the future market and its capacity to reshape obesity treatment paradigms.
- Significant Competitive Advantage: Compared to rival Novo Nordisk's Wegovy, Foundayo offers greater flexibility in dosing and dietary restrictions, and has demonstrated superior efficacy in clinical studies for diabetes patients, which may attract a broader patient base to choose this medication.
- Accelerated Strategic Transformation: Eli Lilly built up a substantial stockpile of the drug ahead of FDA approval to ensure a swift market response, showcasing the company's foresight and execution in its new drug launch strategy, thereby enhancing its competitiveness in the biopharmaceutical industry.
See More
Benchmark Initiates Buy Rating on Palo Alto Networks with $200 Target
- Rating Upgrade: Benchmark has initiated coverage on Palo Alto Networks (PANW) with a Buy rating and a price target of $200, reflecting strong confidence in its future growth, projecting Next Gen Security ARR to more than double from $8.57 billion in FY26 to $20 billion by FY2030.
- Growth Potential: Analyst Yi Fu Lee highlighted that Palo Alto's Next Gen Security ARR grew by 32.4% year-over-year to $6.33 billion, indicating robust performance in the cybersecurity sector, especially when benchmarked against modern high-growth peers.
- Market Resilience: Benchmark asserts that while AI and Quantum Security have yet to be factored into projections, Palo Alto's business model and growth potential provide investors with an additional margin of safety, showcasing its competitive edge in the cybersecurity landscape.
- Industry Stability: Analysts noted that large language model providers like Anthropic and OpenAI are unlikely to disrupt cybersecurity and critical infrastructure software, reinforcing Palo Alto's solid position against AI threats and enhancing its appeal as a core holding.
See More
Market Rises on Optimism Over Iran War Resolution
- Market Optimism: The stock market rose on Tuesday as President Trump expressed willingness to end the Iran War without reopening the Strait of Hormuz, which Jim Cramer noted presents various opportunities, potentially leading to lower oil prices that could alleviate inflation concerns and facilitate interest rate cuts by the Federal Reserve later this year.
- AI Partnership: Nvidia announced a strategic partnership with custom chipmaker Marvell Technology, which is boosting overall sentiment in the artificial intelligence sector, indicating a growing confidence in AI-related investments.
- Cybersecurity Challenges: CEO Nikesh Arora of Palo Alto Networks is on a
See More
Mixed Close for US Stocks as Nasdaq Hits 7.75-Month Low Amid Middle East Tensions
- Divergent Market Performance: On Monday, the S&P 500 index fell by 0.39%, while the Nasdaq 100 hit a 7.75-month low, indicating market concerns over the Middle East situation, particularly exacerbated by a sell-off in chip stocks, which negatively impacted investor confidence.
- Declining Bond Yields: The 10-year T-note yield dropped by 8 basis points to 4.34%, reflecting market fears that the ongoing war in the Middle East could lead to fuel shortages, potentially suppressing expectations for Fed rate hikes and highlighting economic growth uncertainties.
- Rising Crude Oil Prices: Crude oil prices surged over 3% to a three-week high due to Iranian attacks on the Strait of Hormuz, indicating severe threats to global energy supply chains, which could lead to soaring prices in the future and impact the global economy.
- Weak Manufacturing Activity: The Dallas Fed manufacturing activity survey fell to -0.2, below the expected 2.0, reflecting signs of economic slowdown that could influence corporate investment decisions and future economic growth.
See More
High-Quality Stocks Should Not Be Dumped
- Market Sentiment Analysis: Jim Cramer cautions that fear-driven market sentiment is causing investors to dump high-quality stocks, despite their strong fundamentals, indicating an overreaction to short-term volatility.
- Tech Stock Performance: While the S&P 500 and Nasdaq fell by 0.39% and 0.73% respectively, the Dow Jones Industrial Average eked out a 0.11% gain, highlighting a disconnect between tech stocks and overall market performance, particularly in cybersecurity.
- Cybersecurity Outlook: Cramer emphasizes that the rise of artificial intelligence is actually a tailwind for Palo Alto Networks and CrowdStrike, as the increased risk of AI-enabled attacks underscores the necessity of traditional cybersecurity measures.
- CEO Confidence Indicator: The recent $10 million stock purchase by Palo Alto CEO Nikesh Arora suggests strong confidence in the company's future, countering claims that AI poses an existential threat to its business model.
See More
S&P 500 Falls for Third Day; Bond Market Dynamics in Focus
- Bond Yield Movements: The 10-year Treasury yield stands at 4.35%, while the 2-year yield is at 3.838%, indicating investor expectations for a potential rate cut, which could impact stock market performance and trigger shifts in capital flows.
- Oil Price Surge: Amid concerns that the Houthi group in Yemen may attack Israel, both West Texas Intermediate and Brent crude oil futures have risen, reflecting market sensitivity to geopolitical risks that could lead to volatility in energy stocks.
- Palo Alto Networks Stock Fluctuation: The company's shares rose about 5% on Monday, yet they are down 31% from the October peak, highlighting the volatility in market demand for cybersecurity and its potential impact on future performance.
- McCormick Earnings Outlook: The company's stock has fallen 21.6% in the past three months and is down 35% from last March's high, reflecting cautious market sentiment regarding its future performance, which may affect investor confidence.
See More
Eli Lilly Receives FDA Approval for New Drug Foundayo
- New Drug Approval: Eli Lilly announced that its once-daily GLP-1 drug Foundayo has received FDA approval and is set to launch on April 6 via the LillyDirect online platform, addressing strong market demand for weight loss medications and further solidifying its position in the obesity treatment market.
- Positive Market Outlook: Analysts forecast Foundayo to generate approximately $1.55 billion in sales this year, with projections growing to about $14.8 billion by 2030, indicating the drug's significant potential in the future market and its capacity to reshape obesity treatment paradigms.
- Significant Competitive Advantage: Compared to rival Novo Nordisk's Wegovy, Foundayo offers greater flexibility in dosing and dietary restrictions, and has demonstrated superior efficacy in clinical studies for diabetes patients, which may attract a broader patient base to choose this medication.
- Accelerated Strategic Transformation: Eli Lilly built up a substantial stockpile of the drug ahead of FDA approval to ensure a swift market response, showcasing the company's foresight and execution in its new drug launch strategy, thereby enhancing its competitiveness in the biopharmaceutical industry.
See More
Benchmark Initiates Buy Rating on Palo Alto Networks with $200 Target
- Rating Upgrade: Benchmark has initiated coverage on Palo Alto Networks (PANW) with a Buy rating and a price target of $200, reflecting strong confidence in its future growth, projecting Next Gen Security ARR to more than double from $8.57 billion in FY26 to $20 billion by FY2030.
- Growth Potential: Analyst Yi Fu Lee highlighted that Palo Alto's Next Gen Security ARR grew by 32.4% year-over-year to $6.33 billion, indicating robust performance in the cybersecurity sector, especially when benchmarked against modern high-growth peers.
- Market Resilience: Benchmark asserts that while AI and Quantum Security have yet to be factored into projections, Palo Alto's business model and growth potential provide investors with an additional margin of safety, showcasing its competitive edge in the cybersecurity landscape.
- Industry Stability: Analysts noted that large language model providers like Anthropic and OpenAI are unlikely to disrupt cybersecurity and critical infrastructure software, reinforcing Palo Alto's solid position against AI threats and enhancing its appeal as a core holding.
See More
Market Rises on Optimism Over Iran War Resolution
- Market Optimism: The stock market rose on Tuesday as President Trump expressed willingness to end the Iran War without reopening the Strait of Hormuz, which Jim Cramer noted presents various opportunities, potentially leading to lower oil prices that could alleviate inflation concerns and facilitate interest rate cuts by the Federal Reserve later this year.
- AI Partnership: Nvidia announced a strategic partnership with custom chipmaker Marvell Technology, which is boosting overall sentiment in the artificial intelligence sector, indicating a growing confidence in AI-related investments.
- Cybersecurity Challenges: CEO Nikesh Arora of Palo Alto Networks is on a
See More
Mixed Close for US Stocks as Nasdaq Hits 7.75-Month Low Amid Middle East Tensions
- Divergent Market Performance: On Monday, the S&P 500 index fell by 0.39%, while the Nasdaq 100 hit a 7.75-month low, indicating market concerns over the Middle East situation, particularly exacerbated by a sell-off in chip stocks, which negatively impacted investor confidence.
- Declining Bond Yields: The 10-year T-note yield dropped by 8 basis points to 4.34%, reflecting market fears that the ongoing war in the Middle East could lead to fuel shortages, potentially suppressing expectations for Fed rate hikes and highlighting economic growth uncertainties.
- Rising Crude Oil Prices: Crude oil prices surged over 3% to a three-week high due to Iranian attacks on the Strait of Hormuz, indicating severe threats to global energy supply chains, which could lead to soaring prices in the future and impact the global economy.
- Weak Manufacturing Activity: The Dallas Fed manufacturing activity survey fell to -0.2, below the expected 2.0, reflecting signs of economic slowdown that could influence corporate investment decisions and future economic growth.
See More
High-Quality Stocks Should Not Be Dumped
- Market Sentiment Analysis: Jim Cramer cautions that fear-driven market sentiment is causing investors to dump high-quality stocks, despite their strong fundamentals, indicating an overreaction to short-term volatility.
- Tech Stock Performance: While the S&P 500 and Nasdaq fell by 0.39% and 0.73% respectively, the Dow Jones Industrial Average eked out a 0.11% gain, highlighting a disconnect between tech stocks and overall market performance, particularly in cybersecurity.
- Cybersecurity Outlook: Cramer emphasizes that the rise of artificial intelligence is actually a tailwind for Palo Alto Networks and CrowdStrike, as the increased risk of AI-enabled attacks underscores the necessity of traditional cybersecurity measures.
- CEO Confidence Indicator: The recent $10 million stock purchase by Palo Alto CEO Nikesh Arora suggests strong confidence in the company's future, countering claims that AI poses an existential threat to its business model.
See More
S&P 500 Falls for Third Day; Bond Market Dynamics in Focus
- Bond Yield Movements: The 10-year Treasury yield stands at 4.35%, while the 2-year yield is at 3.838%, indicating investor expectations for a potential rate cut, which could impact stock market performance and trigger shifts in capital flows.
- Oil Price Surge: Amid concerns that the Houthi group in Yemen may attack Israel, both West Texas Intermediate and Brent crude oil futures have risen, reflecting market sensitivity to geopolitical risks that could lead to volatility in energy stocks.
- Palo Alto Networks Stock Fluctuation: The company's shares rose about 5% on Monday, yet they are down 31% from the October peak, highlighting the volatility in market demand for cybersecurity and its potential impact on future performance.
- McCormick Earnings Outlook: The company's stock has fallen 21.6% in the past three months and is down 35% from last March's high, reflecting cautious market sentiment regarding its future performance, which may affect investor confidence.
See More
